⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8416084 | 0.97 | — | — | |
| SCHEMBL7960892 | 0.83 | — | — | |
| SCHEMBL7956081 | 0.81 | — | — | |
| SCHEMBL7956067 | 0.80 | — | — | |
| SCHEMBL7954132 | 0.73 | MAPK1 (0.41) | — | |
| SCHEMBL7952021 | 0.73 | MCL1 (0.47) | — | |
| SCHEMBL7958093 | 0.71 | — | — | |
| SCHEMBL7960925 | 0.70 | HPGD (0.42) | — | |
| SCHEMBL7956190 | 0.69 | SCN9A (0.31) | — | |
| SCHEMBL7956114 | 0.69 | MCL1 (0.57) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6271251-B1 | CARDIOVASCULAR DISORDERS | SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) | 2001-08-07 | — | — | US | disclosed |
| EP-0787728-A1 | Substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1997-08-06 | — | — | EP | disclosed |